Arthroplasty S. aureus SSI NI Study
Research type
Research Study
Full title
Epidemiologic study of surgical site infections (SSI) following hip and knee replacement procedures in European countries
IRAS ID
217736
Contact name
Matthew Dryden
Contact email
Sponsor organisation
Pfizer Inc
Clinicaltrials.gov Identifier
N/A, N/A
Duration of Study in the UK
0 years, 5 months, 16 days
Research summary
The proposed study will describe the rates of surgical site infections (SSIs), in patients undergoing hip and/ or knee arthroplasty procedures between July 2013 and June 2015 at approximately 5-10 hospitals in Europe. This is a retrospective cohort with nested case-control study of all SSIs occuring after hip and knee replacement procedures. SSI rates for S. aureus, including methicillin-resistant (MRSA) and methicillin-susceptible Staphylococcus aureus (MSSA), as well as other pathogens will be described. The plan is to have bigger hospitals in the study who have sufficient number of patients, respectively procedures performed in the defined timeframe. The retrospective data collection is planned to start in December 2016 and end in May 2017.
REC name
West of Scotland REC 1
REC reference
17/WS/0015
Date of REC Opinion
21 Feb 2017
REC opinion
Further Information Unfavourable Opinion